Panel finds 30-day course of VTE prophylaxis post-discharge improves outcomes

COVID-19 pill could be available later this year: Pfizer CEO
30 April 2021
Brazil hits 82,000 Covid deaths in April, new monthly record
1 May 2021

Panel finds 30-day course of VTE prophylaxis post-discharge improves outcomes

A new set of guidelines, developed by AATS and ESTS (European Society for Thoracic Surgery) presented today at the AATS 101st Annual Meeting, recommends a 30-day course of Venous Thromboembolism (VTE) prophylaxis post-discharge for patients undergoing surgical resection for lung or esophagus cancer. The AATS and ESTS formed a multidisciplinary guideline panel that included broad membership to minimize potential bias when formulating recommendations. The McMaster University GRADE Centre supported the guideline development process, including updating or performing systematic reviews and meta-analyses. The results are endorsed by the American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis, Inc (ISTH).

Comments are closed.